Navigation Links
Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with,Electroporation DNA Delivery Technology and New Devices at Gene,Therapy Meeting

SAN DIEGO--(BUSINESS WIRE)--Jun 6, 2007 - Inovio Biomedical Corporation (AMEX:INO), focused on the development of DNA vaccines for cancers and infectious diseases and a novel alternative to surgery to treat localized cancers, announced today the company delivered multiple presentations on preclinical study results and new device innovations relating to its electroporation-mediated DNA delivery technology at the 10th Annual Meeting of the American Society of Gene Therapy (ASGT). Inovio's DNA delivery systems are designed to enhance the potency of DNA-based immunotherapies and vaccines against infectious diseases and cancers.

Three presentations reported preclinical data regarding immune responses to DNA vaccines directed against major infectious diseases including malaria, HIV, and hepatitis C, respectively. In all cases, Inovio's electroporation technology was well tolerated and significantly enhanced both humoral (antibody) and cellular (T-cell) immune responses when compared with traditional vaccine delivery methods.

A study conducted in collaboration with the Naval Medical Research Center showed that electroporation-augmented immunization with a DNA vaccine against a malaria parasite-specific antigen not only enhanced humoral and cellular immune responses, but more importantly caused a significant reduction of parasite burden compared to non-immunized control animals.

A study conducted in partnership with Wyeth tested a multi-antigenic DNA vaccine against HIV. Using only one-fifth the dose used without electroporation, antibody responses were increased several hundred-fold by electroporation. The cellular immune response was enhanced 10 to 40-fold, translating into a 50 to 200-fold increase (8 weeks and 22 weeks, respectively) in vaccine potency.

A third study conducted in partnership with the Karolinska Institute, Sweden, supported the safety of electroporation in detailed experiments a
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Vical Interim Clinical Results Demonstrate Safety and Tolerability of Inovio Biomedicals Electroporation DNA Delivery Technology
2. Inovio Biomedicals DNA Delivery Technology Shows Safety and Enhances Gene Expression & Tumor Responses in Interim Melanoma Clinical Study Results
3. Inovio: DNA delivery technology shows positive human results
4. Inovio Biomedicals Partners to Present New Data from Two Cancer Immunotherapy Clinical Trials
5. Inovio Biomedicals DNA Delivery Technology Significantly Enhances Potency of HIV DNA Vaccine
6. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
7. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
8. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
9. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
10. Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting
11. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia

Post Your Comments:
(Date:11/20/2009)..., , NEW YORK, Nov. 20 /PRNewswire-FirstCal...s today contributing to a transformation in Americ...paradigm that is already delivering higher quality...curve downward -- making medicine smarter for the ...mpany today explained how the elements in its stra...
(Date:11/20/2009)..., , NEW YORK, Nov. 20 ...t research report is available in its catalogue. ,...Forecasts to 2015 ,, http://www.reportlinker...sis-and-Forecasts-to-2015.html#utm_source=prnewswi... ,, Description ,, India Medical Equipment...
(Date:11/20/2009)..., , MINNEAPOLIS, Nov. 20 /PRNewswire-FirstCa...unced results for its first quarter ended Septembe... per diluted share, on revenues of $3,263,000. Th...per diluted share, on revenues of $3,168,000 for t... the first quarter results, Biotel President and C...
Breaking Medicine Technology:Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 2Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 3Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 4Medco Reforming Healthcare with 'Smarter Medicine'; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 2Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 3Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 4Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 5Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 6Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 7Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 8Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 9Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 10Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 11Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 12Reportlinker Adds India Medical Equipment Market Analysis and Forecasts to 2015 13Biotel Announced Profitable First Quarter Ended September 30, 2009 2Early initiation of Arctic sea ice formation 9271 1Early initiation of Arctic sea ice formation 9271 2Early initiation of Arctic sea ice formation 9271 3Pulmonx Announces New President and CEO Michael A Baker to Lead Interventional Pulmonology Company 51853 1Pulmonx Announces New President and CEO Michael A Baker to Lead Interventional Pulmonology Company 51853 2Pulmonx Announces New President and CEO Michael A Baker to Lead Interventional Pulmonology Company 51853 3Grubb 26 Ellis Healthcare REIT Signs Agreement to Purchase 16 Building Medical Office Portfolio 51851 1Grubb 26 Ellis Healthcare REIT Signs Agreement to Purchase 16 Building Medical Office Portfolio 51851 2Grubb 26 Ellis Healthcare REIT Signs Agreement to Purchase 16 Building Medical Office Portfolio 51851 3
... Company extension to address remaining questions ...pplication, IRVINE, Calif., Jan. 25 IDM Pharma, ...pany recently presented to the,Committee for Medic...,committee of the European Medicines Evaluation Ag... Application (MAA) for mifamurtide (L-MTP-PE) for,...
...Va., Jan. 25 A report released,today by The Cornu...new,additives placed in infant formula are serious...orns and toddlers., The report, ,Replacing Mother...etails research questioning the alleged benefits o...laboratories and extracted from,algae and fungus, ...
Other Medicine Technology:IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 2IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 3IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 4IDM Pharma Announces Non-Binding Opinion of the European Committee for Medicinal Products for Human Use (CHMP) that Mifamurtide (L-MTP-PE) Provides a Possible Clinical Benefit in Survival 5Infant Formula Manufacturers Again under Ethical Cloud: 'Marketing Gimmick' Linked to Serious Illnesses 2Infant Formula Manufacturers Again under Ethical Cloud: 'Marketing Gimmick' Linked to Serious Illnesses 3
(Date:11/20/2009)...re-USNewswire/ -- The American Dental Association ...ation (FDA) to establish appropriate classificatio...ncern about the safety of whitening products that ...essional consultation or examination by a dentist,...ically based tooth whitening or bleaching agents c...
(Date:11/20/2009)...mber 20 Cardio Vascular,...DICAL.COM , a leading,developer of advanced cardio...the company,s Board of Directors has decided to in...he Far East for its proprietary next-generation,"s... (PCTA) procedures. , Cardio Vascular Med...
(Date:11/20/2009)...ire-USNewswire/ -- The following is a statement by...ealth Care Association: ,, "The Nevada Health C...Majority Leader Harry Reid for his leadership in t...protecting every Nevada seniors, ongoing access to...ength and viability of our state,s vital frontline...
(Date:11/20/2009)...ber 20 in the Journal of the National Cancer Inst...hat often appear in news coverage of cancer resear...edia and journals to help alleviate the problem. ,...in, M.D., M.S., of Center for Medicine and the Med...d Clinical Practice in New Hampshire, and Barnett ...
(Date:11/20/2009)...ldren with chronic kidney disease often fail to de...its increasing a child,s risk for serious heart p...Children,s Center and other institutions. A report...American Society of Nephrology. , Researchers ...ng regular doctor visits to readings obtained via ...
Breaking Medicine News(10 mins):Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Promoting healthy skepticism in the news: Helping journalists get it right 2Health News:High blood pressure easy to miss in children with kidney disease 2
...nnounces the,release of version 7.2 of its integra...ting applications. Therap version 7.2 will feature...ltation Form in the Health,Tracking module and the...avior Event Records are no longer linked. So a...
...l associates will ensure inclusive play ....I., March 1 CVS Caremark announces today,the gra...t Park, bringing,Texas its second Boundless(TM) pl...m the CVS Caremark Charitable Trust, along,with $8...
... medication could boost odds for lymphoma, study f... -- Methotrexate, one of the most common drugs use...raise a patient,s risk for blood cancer, a new stu...d. , The study of almost 24,000 patients over 23 y...
...stimulant treatment and alcohol, drug use , ... of children who are prescribed psychostimulants f... might have one less thing to worry about now that...the National Institutes of Health, is published in...
... damage. If,you are over 40, your skin may be tell...moker (lip lines), those long, lazy sun-worshippin... age spots), or perhaps you,re,seeing a little mor...nd other environmental damage. It,s ugly -- and it...
... 29 /PRNewswire-USNewswire/,-- The Council on Accr...mily Services, application for full Hague Accredit... 2000 (IAA). This achievement of Hague,Accreditati...and Co-operation in,Respect of Intercountry Adopti...
Other Medicine News:Health News:Therap Services Announces Release 7.2 for the Developmental Disability Community 2Health News:Therap Services Announces Release 7.2 for the Developmental Disability Community 3Health News:CVS Caremark All Kids Can Program Announces the Opening of a Boundless(TM) Playground in Dallas to Serve Children of all Abilities 2Health News:CVS Caremark All Kids Can Program Announces the Opening of a Boundless(TM) Playground in Dallas to Serve Children of all Abilities 3Health News:Common Rheumatoid Arthritis Drug Won't Raise Blood Cancer Risk 2Health News:Common Rheumatoid Arthritis Drug Won't Raise Blood Cancer Risk 3Health News:ADHD Drugs Won't Raise Risk of Substance Abuse 2Health News:ADHD Drugs Won't Raise Risk of Substance Abuse 3Health News:The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing 2Health News:The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing 3Health News:The DOT CO2 Fractional: The Next Step in Laser Skin Resurfacing 4Health News:Children's Home Society & Family Services Achieves Full Hague Accreditation 2
Automatic Tangent Screen
Focus Toric Monthly lenses
...Made Toric soft contact lenses let you enjoy a lev...ns in a lens custom made to fit your eye., Th...y PC Technology™, which creates a unique mat...C), a substance found naturally in human cell memb...
Hydrasoft® Toric
Medicine Products: